Tacrolimus-based immunosuppression in renal transplantation: 78 experiences in a single Japanese center.
Okamoto
M
M
Department of Transplantation and Endocrine Surgery, Kyoto Prefectural University of Medicine, 465 Kajicho, Kawaramachi-Hirokoji, 602 Kamigyo-ku, Kyoto, Japan.
Omori
Y
Y
Kadotani
Y
Y
Ushigome
H
H
Nakamura
K
K
Akioka
K
K
Yoshimura
N
N
D000293:Adolescent; D000328:Adult; D002648:Child; D004305:Dose-Response Relationship, Drug; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D007564:Japan; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008875:Middle Aged; D012086:Reoperation; D016559:Tacrolimus / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016559:Tacrolimus